FDA authorizes Pfizer booster shots for older teens
CDC Director Dr. Rochelle Walensky’s sign off means 16- and 17-year-olds can begin immediately begin getting their boosters.
The Centers for Disease Control and Prevention on Thursday signed off on booster shots of the Pfizer-BioNTech COVID-19 vaccine for 16- and 17-year-olds for emergency use. Acting FDA Commissioner Dr. Janet Woodcock said boosters, along with other preventative measures, remain the nation’s most effective method for fighting COVID-19.
The Pfizer booster will be available to 16- and 17-year-olds at least six months after they received their second dose of the Pfizer vaccine. Because Pfizer’s vaccine and booster shots are the only ones that have been cleared for use in children under 18, “mixing and matching” vaccines and boosters is not an option for this age group. The Moderna and Johnson & Johnson vaccines are authorized for adults 18 and up.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC Chief Dr. Rochelle Walensky Says Omicron Mostly Mild So FarMore than 40 people in the U.S. have been diagnosed with the omicron variant so far, but nearly all of them were only mildly ill -- even the unvaccinated patients.
Read more »
Pfizer, BioNTech vaccine neutralises Omicron with three shotsBioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed.
Read more »
Pfizer says booster shot of its vaccine protects against omicron variantOmicron variant vaccine research from Pfizer-BioNTech appears to show the Pfizer Covid vaccine booster dose can provide strong protection against omicron.
Read more »
Omicron live updates: New study suggests Pfizer-BioNTech vaccine may only partially protect against variantJUST IN: New preliminary study suggests Pfizer-BioNTech vaccine may only partially protect against omicron variant, but that a booster offers greater protection.
Read more »
Omicron variant partly evades Pfizer vaccine's protection, study showsThe Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine, but people who have been previously infected and then vaccinated are likely to be well protected, researchers working in South Africa reported Tuesday.
Read more »
Two vaccine doses may not provide sufficient protection against Omicron coronavirus variant, Pfizer saysPreliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday.
Read more »